Dean R. O'Neill Renal Cell Cancer Research Fund

Founded in 2003 by the O’Neill family, the Dean R. O'Neill Renal Cell Cancer Research Fund at the FNIH supports a Post-Baccalaureate Fellow in the laboratory of Dr. Richard Childs at the National Heart, Lung, and Blood Institute (NHLBI) to search for a cure for renal cell carcinoma. Commonly referred to as kidney cancer, renal cell carcinoma is an under-researched and growing disease that is diagnosed in more than 50,000 individuals each year.

With the support of the O’Neill Fund, the Fellow in Dr. Childs’ lab explores treatments such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy and drug treatments.

This fund is complementary to and in concert with the Dr. Edward T. Rancic Memorial Fund for Cancer Research and the annual Boo! Run for Life 10K Run and Tidal Basin Walk, and is supported by generous contributions from individuals.

Read the Department of Health & Human Services’ Post-Baccalaureate Student Progress Report (July 16, 2015) here.

Goals

  • Support a Fellow in Dr. Richard Childs’ laboratory to explore treatments such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy and drug treatments.

Results & Accomplishments

In 2007, the first O’Neill Fellow made an important discovery in genetic mechanisms found in 50 percent of all kidney cancer patients. This discovery, made by Dr. Nanae Harashima and the team of doctors in Dr. Childs' lab, has led to new treatments to stem the cancer’s spread and has given new hope for a cure. Learn more about Dr. Childs’ research here.

Media

Video: Learn about the launch of the fellowship.

Support

To make a gift in support of the Dean R. O’Neill Cancer Research Fund, click here

 

Partners

Dean R. O'Neill Renal Cell Cancer Research Fund
National Heart, Lung, and Blood Institute (NHLBI)

Contacts

Jamie Cooper, Advancement Officer, Jcooper@fnih.org